STUDY ON THE PHARMACOKINETICS AN RELATIVE BIOAVAILABILITIES OF OFLOXACINS IN HEALTH VOLUNTEERS
Chen Tie-sha
Abstract
Chen Tie-sha
Abstract
Objective:Compared with ofloxacin tablets,to study the pharmacokineties and relative bioavailabilities of ofloxacin capsules.Methods:10 male health volunteers orally took a single does of 300mg ofloxacins in randomized selfcrossover way.ofloxacin concetration was determined by high performance liquid chromatography.Data of serum level-time were disposed with PKBP-N1 of software and computer.Results:The concentration time data of ofloxacin was fitted to two compartment model and the main pharmacokinetic parameters are as following sapsule:C max =(5.22±0.87)ug/ml;T max =(0.96±0.04)h;AUC 0-24 =(33.46±3.92)μg/(ml·h);t 1/2 (β)=6.02±0.40)h.Tablet:C max (5.09±0.77)μg/ml;T max =(0.89±0.21)h;AUC 0-24 =(31.46±2.8)μg/ml·h;t 1/2 (β)=(6.12±0.39)h.Relative:Bioavaiability of capsule was (106.23±5.63).Compared with tablet.Conclusion:The two formulations are of bioequivaicnce.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:Compared with ofloxacin tablets,to study the pharmacokineties and relative bioavailabilities of ofloxacin capsules.Methods:10 male health volunteers orally took a single does of 300mg ofloxacins in randomized selfcrossover way.ofloxacin concetration was determined by high performance liquid chromatography.Data of serum level-time were disposed with PKBP-N1 of software and computer.Results:The concentration time data of ofloxacin was fitted to two compartment model and the main pharmacokinetic parameters are as following sapsule:C max =(5.22±0.87)ug/ml;T max =(0.96±0.04)h;AUC 0-24 =(33.46±3.92)μg/(ml·h);t 1/2 (β)=6.02±0.40)h.Tablet:C max (5.09±0.77)μg/ml;T max =(0.89±0.21)h;AUC 0-24 =(31.46±2.8)μg/ml·h;t 1/2 (β)=(6.12±0.39)h.Relative:Bioavaiability of capsule was (106.23±5.63).Compared with tablet.Conclusion:The two formulations are of bioequivaicnce.
Key concepts: Ofloxacin, Pharmacokinetics, Medicine, Capsule, Bioavailability, Pharmacology, Chromatography, Chemistry